PAR:LNA

LNA Santé S.A. · PAR · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:07 UTC

Last close

n/aEUR

Market data

11.2xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
3.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.6%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
6.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.75Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.5%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.21 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

192

2016-12-31 to 2025-12-31100 at the start192

Sales: 100.00 on 2016-12-31 to 192.13 on 2025-12-31, up 92%.

Profit

112

2016-12-31 to 2025-12-31100 at the start112

Profit: 100.00 on 2016-12-31 to 111.67 on 2025-12-31, up 12%.

Shares in issue

114

2016-12-31 to 2025-12-31100 at the start114

Shares in issue: 100.00 on 2016-12-31 to 113.72 on 2025-12-31, up 14%.

Sales is at 192, Profit is at 112, Shares in issue is at 114, against 100 in 2016.

Sales is at 192, Profit is at 112, Shares in issue is at 114, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100192
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100112
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100114
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR